Inventor · disambiguated record
Laurens Kruidenier
Also filed as: KRUIDENIER LAURENS
4 granted patents·4 pending applications·34 citations·filing 2011–2025
74Inventor score
Top patents by PatentIndex Score
8 records- 0194US11136386B2Methods of treating Crohn's disease or ulcerative colitis by administering inhibitors of tumor necrosis factor-like cytokine 1A (TL1A)PROMETHEUS BIOSCIENCES INC·Filed 2020·Granted Oct 5, 2021·12 cites·53 claims
- 0287US12215147B2Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-TL1A antibodyPROMETHEUS BIOSCIENCES INC·Filed 2021·Granted Feb 4, 2025·1 cites·45 claims
- 0386US8691747B2Method of treatment based on ATAD2 inhibitorsKRUIDENIER LAURENS·Filed 2011·Granted Apr 8, 2014·21 cites·1 claims
- 0482US12391752B2Methods of enriching or amplifying nucleic acids in a sample from a patient with inflammatory bowel diseasePROMETHEUS BIOSCIENCES INC·Filed 2023·Granted Aug 19, 2025·0 cites·34 claims
- 0582US2025340627A1Methods of selecting, based on polymorphisms, an inflammatory bowel disease subject for treatment with an anti-tl1a antibodyPROMETHEUS BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 0666US2020362025A1Tl1a patient selection methods, systems, and devicesPROMETHEUS BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 0762US2023272098A1Methods, systems, and kits for treatment of inflammatory diseases targeting tl1aPROMETHEUS BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0844US2015203851A1Inhibitors of bromodomain-containing protein pcaf for the treatment of autoimmune and inflammatory diseases or for the treatment of cancerGLAXO GROUP LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Laurens Kruidenier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →